3rd Quarter - Termination

FORBES-TATE for EMERGENT BIOSOLUTIONS

Firm
Client
Income
$20,000
Expenses
—
Terminated
Jul 31, 2023

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues regarding opioid and heroin addiction legislation, naloxone access and awareness, and opioid prescribing guidelines; Appropriations funding for Fiscal Year 2022, Further Extending Government Funding Act (PL 117-70); Issues related to the development, manufacture, and distribution of coronavirus vaccines; Outreach regarding H.R. 3263 - DHS Medical Countermeasures Act (117th Congress); FY 2024 National Defense Authorization Act - provisions related to biological and chemical defense and access to naloxone; Issues related to H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 (117th Congress); H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 (117th Congress); Issues related to the implementation of PREVENT Pandemics Act in Consolidated Appropriations Act, 2023 (PL 117-328).

Contacted: Health & Human Services, Dept of (HHS); Office of Natl Drug Control Policy (NDCP); Centers For Disease Control & Prevention (CDC); SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Justice, Dept of (DOJ); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3263 (118th), H.R. 7681 (118th), H.R. 7666 (118th)

Budget/Appropriations BUD

Issues regarding State Opioid Response Grant funding; Issues regarding Substance Abuse and Mental Health Block Grant funding; S. 987/H.R. 4341 - Comprehensive Addiction and Recovery Act (CARA) 3.0 (117th Congress); H.R. 2379 - State Opioid Response Grant Authorization Act of 2021 (117th Congress); H.R 2366/S.1457 - Stop Fentanyl Act (117th Congress); H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 (117th Congress); Issues related to the development, manufacture, and distribution of coronavirus vaccines; FY23 Omnibus appropriations bill (PL 117-328) and FY24 appropriations bills; Further Extending Government Funding Act (PL 117-70); Appropriations funding for FY23 related to medical countermeasures and opioid overdose; Issues regarding funding of the Strategic National Stockpile.

Contacted: Justice, Dept of (DOJ); Office of Management & Budget (OMB); Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Office of Natl Drug Control Policy (NDCP); Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 2366 (118th), H.R. 5224 (118th), S. 1457 (118th), H.R. 4341 (118th), H.R. 2379 (118th), S. 987 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.